Had a look at top pharma market caps in USA and they range from around 380B and down... Sooooo perhaps not that infeasible... Especially considering I read (and can't remember where in one of their announcements or something) that they have strategies in place to offset any potential lost profitability from generics.
Sounds like they have a lot up their sleeves... and based on that and 380B valuations, a 50B valuation could be feasible (especially considering i'm talking 10-20yrs down the track)
MYX Price at posting:
70.3¢ Sentiment: Buy Disclosure: Held
